Impossible Dreams, ALS Journey & Breakthroughs

Details

Description

Hosted by Aaron Lazar | Guest: Alon Ben-Noon, CEO of NeuroSense Therapeutics

This episode is part heart, part science, and all purpose.
Join Grammy-nominated Broadway and screen star Aaron Lazar, diagnosed with ALS 3.5 years ago-as he sits down with Alon Ben-Noon, the founder and CEO of NeuroSense Therapeutics, to discuss their shared mission: changing the future of ALS.

From deeply personal reflections to the latest updates on PrimeC, a promising ALS therapy now heading into Phase 3 trials, this conversation explores:

✅ Aaron’s journey from diagnosis to advocacy
✅ The story behind NeuroSense and its patient-driven mission
✅ PrimeC’s clinical progress and regulatory path in Canada & the U.S.
✅ What it takes to run a biotech with heart — and urgency
✅ How partnership, persistence, and purpose are fueling real hope

🔑 Topics include:
• Patient access to PrimeC
• Updates on Health Canada’s NOC/c review
• Status of strategic pharma partnerships
• Capital strategy & protecting shareholder value
• What’s next for NeuroSense - and for Aaron Lazar

🎵 The episode closes with Aaron’s moving rendition of “The Impossible Dream” — a reminder of why this fight matters so deeply.

🧠 For anyone touched by ALS - or inspired by stories of courage and innovation - this is a must-watch.

🔔 Subscribe for updates on clinical trials, regulatory progress, and future episodes of Impossible Dreams.